Skip to content

Association between Preoperative Use of SGLT2 Inhibitors and Postoperative Hyperketonemia in Patients Undergoing Elective Surgery: A Multicenter Cohort Study

Association between Preoperative Use of SGLT2 Inhibitors and Postoperative Hyperketonemia in Patients Undergoing Elective Surgery: A Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129235
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic ketoacidosis

Interventions

Group E (ultra-long discontinuation group):None
Group C (guideline-standard group):None
Group B (moderate exposure level):None
Group A (highest exposure level / highest risk group):None
Group D (prolonged discontinuation group):None

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–85 years; 2. Preoperatively confirmed diagnosis of type 2 diabetes mellitus and continuous regular use of SGLT2 inhibitors prior to hospital admission; 3. Planned to undergo elective abdominal surgery under general anesthesia with an expected operative duration >2 hours; 4. Agree to and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of hyperketoacidemia (blood ketone >3 mmol/L) before anesthesia; 2. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Incidence of hyperketonemia during intraoperative or postoperative hospital stay;

Secondary

MeasureTime frame
Acute kidney injury (AKI);Length of postoperative hospital stay;ICU admission rate;Major cardiovascular and cerebrovascular complications;Respiratory complications;Mortality during hospitalization;

Countries

China

Contacts

Public ContactLining Huang

The Second Hospital of Hebei Medical University

15803213730@163.com+86 311 66003887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026